RACRace Oncology Limited

RAC Stock Price, Valuation & Chart | Race Oncology Limited

Compare

$2.140-0.07 (-3.17%)

At close · 03 Sept 2026, 06:10 am

Sector: Healthcare Industry: Biotechnology RAC intrinsic value RAC calculated fair value vs price Website

Overview Financials Dividends Ratios

RAC Historical price chart

RAC Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization419.59M

PE Ratio-34.57

EPS-0.06

Trading Volume60.37K

Today's High/Low2.21/2.12

Dividend Yield0.00

52 Week High/Low4.9/1.33

Shares Outstanding196.07M

RAC Financial Statement

RAC Analyst ratings

Buy

Strong buy

Buy

Hold

Sell

Strong sell

Based on 0 analysts giving stock ratings to RAC in the past 3 months.

RAC Analysis & performance metrics

RAC Company profile

Race Oncology Limited operates as a precision oncology company in Australia. The company is developing Zantrene, a potent small molecule inhibitor of the fatso/fat mass and…

Race Oncology Limited operates as a precision oncology company in Australia. The company is developing Zantrene, a potent small molecule inhibitor of the fatso/fat mass and obesity associated protein to treat for melanoma and clear cell renal cell carcinoma, as well as acute myeloid leukaemia, breast, and ovarian cancers, which is in Phase II/III clinical trial. It has a preclinical…

RAC Management team

Name

Position

Michelle Rashford

Chief Medical Officer

Peter M. Smith Ph.D.

Executive Chairman

Peter Gordon Webse B.Bus, FCIS, FCPA, FGIA, M.A.I.C.D.

Company Secretary

Sophia Moscovis

Vice President of Operations & Strategy

Daniel TillettCEO

Chief Executive Officer, Managing Director & Director

Brendan BrownCFO

Chief Financial Officer

Name

Position

Michelle Rashford

Chief Medical Officer

Peter M. Smith Ph.D.

Executive Chairman

Peter Gordon Webse B.Bus, FCIS, FCPA, FGIA, M.A.I.C.D.

Company Secretary

Sophia Moscovis

Vice President of Operations & Strategy

Daniel TillettCEO

Chief Executive Officer, Managing Director & Director

Brendan BrownCFO

Chief Financial Officer

Management Team

Michelle Rashford

Chief Medical Officer

Peter M. Smith Ph.D.

Executive Chairman

Peter Gordon Webse B.Bus, FCIS, FCPA, FGIA, M.A.I.C.D.

Company Secretary

Sophia Moscovis

Vice President of Operations & Strategy

Daniel TillettCEO

Chief Executive Officer, Managing Director & Director

Brendan BrownCFO

Chief Financial Officer

Management

Michelle Rashford

Chief Medical Officer

Peter M. Smith Ph.D.

Executive Chairman

Peter Gordon Webse B.Bus, FCIS, FCPA, FGIA, M.A.I.C.D.

Company Secretary

Sophia Moscovis

Vice President of Operations & Strategy

Daniel TillettCEO

Chief Executive Officer, Managing Director & Director

Brendan BrownCFO

Chief Financial Officer

Total 6 executives

RAC Frequently asked questions

What is Race Oncology Limited (RAC) Stock Price?

Current stock price of Race Oncology Limited (RAC) stock is $2.140. The stock price is -3.17% lower in the session. The intraday range can be seen from this page. Volume of Race Oncology Limited (RAC) stock is 60.37K.

Last updated at 03 Sept 2026, 06:10 am.

Why is the Race Oncology Limited (RAC) stock price going up or down today?

The stock price of Race Oncology Limited (RAC) can change with earnings, company news, and overall market sentiment. Race Oncology Limited operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Race Oncology Limited stock expensive at its current price?

Whether Race Oncology Limited looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for RAC on this page is -34.57. EPS on this page is -0.06. Compare those figures with peers and growth expectations before deciding if the current Race Oncology Limited price is justified.

How has the stock price of Race Oncology Limited (RAC) performed historically?

Historical performance for Race Oncology Limited (RAC) is shown on the price chart on this page. Review multi-period moves alongside volume to see how RAC reacted to past earnings and market events.

Should I buy Race Oncology Limited (RAC) stock, at this price?

Buying Race Oncology Limited (RAC) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.